Document:

Exhibit 10.6.2

 

RESTRICTED STOCK UNIT AWARD AGREEMENT

 

ZYVERSA THERAPEUTICS, INC.

 

This Restricted Stock Unit
Award Agreement (the “Agreement” or “Award Agreement”), dated as of the “Award Date”
set forth in the attached Exhibit A, is entered into between Zyversa Therapeutics, Inc., a Delaware corporation (the “Company”),
and the individual named in Exhibit A hereto (the “Awardee”).

 

WHEREAS, the Company desires
to provide the Awardee with an opportunity to acquire the Company’s common shares, par value $.0001 per share (the “Common
Stock”), and thereby provide additional incentive for the Awardee to promote and participate in the progress and success of
the business of the Company; and

 

WHEREAS, to give effect to
the foregoing intention, the Company desires to award the Awardee Restricted Stock Units pursuant to the Zyversa Therapeutics, Inc. 2022
Omnibus Equity Incentive Plan (the “Plan”);

 

NOW, THEREFORE, the following
provisions apply to this Award:

 

1.   Award.
The Company hereby awards the Awardee the number of Restricted Stock Units (each an “RSU” and collectively the “RSUs”)
set forth in Exhibit A. Such RSUs shall be subject to the terms and conditions set forth in this Agreement and the provisions of
the Plan, the terms of which are incorporated herein by reference. Capitalized terms used but not otherwise defined herein shall have
the meanings as set forth in the Plan.

 

2.   Vesting
and settlement.

 

(a)
Vesting. Except as otherwise provided in this Agreement, the RSUs shall vest in accordance with the vesting schedule set
forth in Exhibit A, provided that the Awardee remains in Continuous Service through each applicable vesting date.

 

(b)
Settlement. For each RSU that becomes vested in accordance with this Agreement, the Company shall issue and deliver to Awardee
one share of Common Stock. Such shares shall be issued and delivered as soon as administratively practicable following the vesting date
of each such RSU, but in no event later than March 15 of the year following the year in which such vesting date occurs. Except as provided
above, in the event that the Awardee ceases to be in Continuous Service, any RSUs that have not vested as of the date of such cessation
of service shall be forfeited. If requested by the Awardee, delivery of shares may be effected by book-entry credit to the Awardee’s
brokerage account.

 

3.   Dividend
Equivalent Units. If and to the extent that the Company pays a cash dividend with respect to the Common Stock, Awardee shall be credited
with an additional number of RSUs (“Dividend Equivalent Units”), including a fractional Dividend Equivalent Unit if
applicable, equal to (i) the amount of such dividends as would have been paid with respect to Awardee’s outstanding RSUs on the
record date of such dividend (the “record date”) had each such outstanding RSU been an outstanding share of Common
Stock on such record date, divided by (ii) the closing price of a share of Common Stock on such record date. Dividend Equivalent Units
shall be subject to the same vesting terms and conditions as the RSUs to which they relate.

 

     

     

    

 

4.   No
Rights as Stockholder. The Awardee shall not be entitled to any of the rights of a stockholder with respect to any share of Common
Stock that may be acquired following vesting of an RSU unless and until such share of Common Stock is issued and delivered to the Awardee.
Without limitation of the foregoing, the Awardee shall not have the right to vote any share of Common Stock to which an RSU relates and
shall not be entitled to receive any dividend attributable to such share of Common Stock for any period priot to the issuance and delivery
of such share to Awardee (but Awardee shall have dividend equivalent rights as provided in Section 3 above).

 

5.   Transfer
Restrictions. Neither this Agreement nor the RSUs may be sold, assigned, pledged or otherwise transferred or encumbered without the
prior written consent of the Committee.

 

6.   Government
Regulations. Notwithstanding anything contained herein to the contrary, the Company’s obligation hereunder to issue or deliver
certificates evidencing shares of Common Stock shall be subject to the terms of all applicable laws, rules and regulations and to such
approvals by any governmental agencies or national securities exchanges as may be required.

 

7.   Investment
Purpose. Any and all shares of Common Stock acquired by the Awardee under this Agreement will be acquired for investment for the Awardee’s
own account and not with a view to, for resale in connection with, or with an intent of participating directly or indirectly in, any distribution
of such shares of Common Stock within the meaning of the Securities Act of 1933, as amended (the “Securities Act”).
The Awardee shall not sell, transfer or otherwise dispose of such shares unless they are either (1) registered under the Securties Act
and all applicable state securities laws, or (2) exempt from such registration in the opinion of Company counsel.

 

8.   Securities
Law Restrictions. Regardless of whether the offering and sale of shares of Common Stock issuable to Awardee pursuant to this Agreement
and the Plan have been registered under the Securities Act, or have been registered or qualified under the securities laws of any state,
the Company at its discretion may impose restrictions upon the sale, pledge or other transfer of such shares of Common Stock (including
the placement of appropriate legends on stock certificates or the imposition of stop-transfer instructions) if, in the judgment of the
Company, such restrictions are necessary in order to achieve compliance with the Securities Act or the securities laws of any state or
any other law.

 

9.   Lock-Up
Agreement. The Awardee, in the event that any shares of Common Stock which become deliverable to Awardee with respect to RSUs at a
time during which any directors or officers of the Company have agreed with one or more underwriters not to sell securities of the Company,
shall enter into an agreement, in form and substance satisfactory to the Company, pursuant to which the Awardee shall agree to restrictions
on transferability of the shares of such Common Stock comparable to the restrictions agreed upon by such directors or officers of the
Company.

 

    - 2 -

     

    

 

10.   Awardee
Obligations. The Awardee should review this Agreement with his or her own tax advisors to understand the federal, state, local and
foreign tax consequences of the transactions contemplated by this Agreement. The Awardee will rely solely on such advisors and not on
any statements or representations of the Company or any of its agents, if any, made to the Awardee. The Awardee (and not the Company)
shall be responsible for the Awardee’s own tax liability arising as a result of the transactions contemplated by this Agreement.

 

11.   No
Guarantee of Continued Service. Nothing in this Agreement or the Plan confers on the Awardee any right to remain in Continuous Service,
nor shall it affect in any way any right of the Awardee or the Company to terminate the Awardee’s service relationship.

 

12.   Notices.
Notices or communications to be made hereunder shall be in writing and shall be delivered in person, by registered mail, by confirmed
facsimile or by a reputable overnight courier service to the Company at its principal office or to the Awardee at his or her address contained
in the records of the Company. Alternatively, notices and other communications may be provided in the form and manner of such electronic
means as the Company may permit.

 

13.   Entire
Agreement; Governing Law. The Plan is incorporated herein by reference. The Plan and this Award Agreement constitute the entire Agreement
with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and the
Awardee with respect to the subject matter hereof, and except as provided in the Plan or in this Agreement, may not be modified adversely
to the Awardee’s interest except by means of a writing signed by the Company and the Awardee. In the event of any conflict between
this Award Agreement and the Plan, the Plan shall be controlling. This Award Agreement shall be construed under the laws of the State
of Delaware, without regard to conflict of laws principles.

 

14.   Opportunity
for Review. Awardee and the Company agree that this Award is granted under and governed by the terms and conditions of the Plan and
this Award Agreement. The Awardee has reviewed the Plan and this Award Agreement in their entirety, has had an opportunity to obtain the
advice of counsel prior to accepting this Award Agreement and fully understands all provisions of the Plan and this Award Agreement. The
Awardee hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions
relating to the Plan and this Award Agreement. The Awardee further agrees to notify the Company upon any change in Awardee’s residence
address.

 

15.   Binding
Effect. This Agreement shall be binding upon and inure to the benefit of the Company and the Awardee and their respective permitted
successors, assigns, heirs, beneficiaries and representatives.

 

16.   Section
409A Compliance. To the extent that this Agreement and the award of RSUs hereunder are or become subject to the provisions of Section
409A of the Code, the Company and the Awardee agree that this Agreement may be amended or modified by the Company, in its sole discretion
and without the Awardee’s consent, as appropriate to maintain compliance with the provisions of Section 409A of the Code.

 

[Signature Page Follows]

 

    - 3 -

     

    

  

IN WITNESS WHEREOF, the parties
hereto have executed this Agreement as of the date set forth in Exhibit A.

 

	 	ZYVERSA
    THERAPEUTICS, INC.
	 	 
	 	By:	                                   
	 	 	Name:
	 	 	Title:
	 	 	 
	 	AWARDEE
	 	 
	 	 
	 	Name:	 

 

    - 4 -

     

    

 

EXHIBIT
A

 

ZYVERSA THERAPEUTICS, INC.

 

RESTRICTED STOCK UNIT AWARD AGREEMENT

 

 

 

(a).
Awardee’s Name: __________________________________

 

(b).
Award Date:  __________________________________

 

(c). Number
of Restricted Stock Units (“RSUs”) Granted:  ________________________

 

(d).   Vesting
Schedule: [Twenty-five percent (25%)] of the RSUs shall vest on the one-year anniversary of the Award Date (the “First Vesting
Date”) and the remaining [seventy-five percent (75%)] of the RSUs shall vest in equal quarterly installments over the following
three year period, commencing with the three month anniversary of the First Vesting Date and continuing on each three month anniversary
of the First Vesting Date thereafter; provided that Optionee is in Continuous Service on each such respective vesting date.

 

  _______(Initials)

 Awardee

 

  _______(Initials)

 Company Signatory

 

 

- 5 -Exhibit 10.6.3

 

NONQUALIFIED STOCK OPTION GRANT AGREEMENT

 

ZYVERSA THERAPEUTICS, INC.

 

This Stock Option Grant Agreement
(the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the
“Date of Grant”) by and between Zyversa Therapeutics, Inc., a Delaware corporation (the “Company”),
and the individual named in Exhibit A hereto (the “Optionee”).

 

WHEREAS, the Company desires
to provide the Optionee an incentive to participate in the success and growth of the Company through the opportunity to earn a proprietary
interest in the Company; and

 

WHEREAS, to give effect to
the foregoing intention, the Company desires to grant the Optionee an option pursuant to the Zyversa Therapeutics, Inc. 2022 Omnibus Equity
Incentive Plan (the “Plan”) to acquire the Company’s common stock, par value $0.0001 per share (the “Common
Stock”);

 

NOW, THEREFORE, in consideration
of the mutual covenants hereinafter set forth and for good and valuable consideration, the parties hereto agree as follows:

 

1.   Grant.
The Company hereby grants the Optionee a Nonqualified Stock Option (the “Option”) to purchase up to the number of shares
of Common Stock (the “Shares”) set forth in Exhibit A hereto at the exercise price per Share (the “Exercise
Price”) set forth in Exhibit A, and on the vesting schedule set forth in Exhibit A, subject to the terms and conditions
set forth herein and the provisions of the Plan, the terms of which are incorporated herein by reference. Capitalized terms used but not
otherwise defined in this Grant Agreement shall have the meanings as set forth in the Plan.

 

2.   Exercise
Period Following Termination of Continuous Service. This Option shall terminate and be canceled to the extent not exercised within
ninety (90) days after the Optionee’s Continuous Service terminates, except that if such termination is due to the death or Disability
of the Optionee, this Option shall terminate and be canceled one (1) year from the date of termination of Continuous Service. Notwithstanding
the foregoing, in the event that the Optionee’s Continuous Service is terminated for Cause, then the Option shall immediately terminate
on the date of such termination of Continuous Service and shall not be exercisable for any period following such date. In no event, however,
shall this Option be exercised later than the Expiration Date set forth in Exhibit A and in no event shall this Option be exercised
for more Shares than the Shares which otherwise have become exercisable as of the date of termination.

 

3.   Method
of Exercise. This Option is exercisable by delivery to the Company of an exercise notice (the “Exercise Notice”)
in a form satisfactory to the Committee or by such other form or means as the Committee may permit or require. A sample Exercise Notice
is attached as Exhibit B. The Committee may, however, require Optionee to submit a different form of Exercise Notice. Any Exercise
Notice shall state or provide the number of Shares with respect to which the Option is being exercised (the “Exercised Shares”),
and include such other representations and agreements as may be required by the Company pursuant to the provisions of the Plan. The Exercise
Notice shall be accompanied by payment of the aggregate Exercise Price for the Exercised Shares in (i) cash; (ii) check; or (iii) such
other manner as is acceptable to the Committee, provided that such form of consideration is permitted by the Plan and by applicable law.
Upon exercise of the Option by the Optionee and prior to the delivery of such Exercised Shares, the Company shall have the right to require
the Optionee to satisfy applicable Federal and state tax income tax withholding requirements and the Optionee’s share of applicable
employment withholding taxes in a method satisfactory to the Company. Notwithstanding the foregoing, no Exercised Shares shall be issued
unless such exercise and issuance complies with the requirements relating to the administration of stock option plans and other applicable
equity plans under U.S. state corporate laws, U.S. federal and state securities laws, the Code, any stock exchange or quotation system
on which the Common Stock is listed or quoted, and the applicable laws of any foreign country or jurisdiction where stock grants or other
applicable equity grants are made under the Plan; assuming such compliance, for income tax purposes the Exercised Shares shall be considered
transferred to the Optionee on the date the Option is exercised with respect to such Shares.

 

     

     

    

 

4.   Covenants
Agreement. This Option shall be subject to forfeiture at the election of the Company in the event that the Optionee breaches any agreement
between the Optionee and the Company with respect to noncompetition, nonsolicitation, assignment of inventions and contributions and/or
nondisclosure obligations of the Optionee.

 

5.   Taxes.
By executing this Grant Agreement, Optionee acknowledges and agrees that Optionee is solely responsible for the satisfaction of any applicable
taxes that may be imposed on Optionee that arise as a result of the grant, vesting or exercise of the Option, including without limitation
any taxes arising under Section 409A of the Code (regarding deferred compensation) or Section 4999 of the Code (regarding golden parachute
excise taxes), and that neither the Company nor the Committee shall have any obligation whatsoever to pay such taxes or otherwise indemnify
or hold Optionee harmless from any or all of such taxes.

 

6.   Non-Transferability
of Option. This Option may not be transferred in any manner otherwise than by will or by the laws of descent or distribution and may
be exercised during the lifetime of the Optionee only by the Optionee. The terms of the Plan and this Grant Agreement shall be binding
upon the executors, administrators, heirs, successors and assigns of the Optionee.

 

7.   Securities
Matters. All Shares and Exercised Shares shall be subject to the restrictions on sale, encumbrance and other disposition provided
by Federal or state law. The Company shall not be obligated to sell or issue any Shares or Exercised Shares pursuant to this Grant Agreement
unless, on the date of sale and issuance thereof, such Shares are either registered under the Securities Act of 1933, as amended (the
“Securities Act”), and all applicable state securities laws, or are exempt from registration thereunder. Regardless
of whether the offering and sale of Shares under the Plan have been registered under the Securities Act, or have been registered or qualified
under the securities laws of any state, the Company at its discretion may impose restrictions upon the sale, pledge or other transfer
of such Shares (including the placement of appropriate legends on stock certificates or the imposition of stop-transfer instructions)
if, in the judgment of the Company, such restrictions are necessary in order to achieve compliance with the Securities Act or the securities
laws of any state or any other law.

 

8.   Investment
Purpose. The Optionee represents and warrants that unless the Shares are registered under the Securities Act, any and all Shares acquired
by the Optionee under this Grant Agreement will be acquired for investment for the Optionee’s own account and not with a view to,
for resale in connection with, or with an intent of participating directly or indirectly in, any distribution of such Shares within the
meaning of the Securities Act. The Optionee agrees not to sell, transfer or otherwise dispose of such Shares unless they are either (1)
registered under the Securties Act and all applicable state securities laws, or (2) exempt from such registration in the opinion of Company
counsel.

 

    -2-

     

    

 

9.   Lock-Up
Agreement. The Optionee hereby agrees that in the event that the Optionee exercises this Option during a period in which any directors
or officers of the Company have agreed with one or more underwriters not to sell securities of the Company, then, as a condition to such
exercise, the Optionee shall enter into an agreement, in form and substance satisfactory to the Company, pursuant to which the Optionee
shall agree to restrictions on transferability of the Shares comparable to the restrictions agreed upon by such directors or officers
of the Company.

 

10.   Other
Plans. No amounts of income received by the Optionee pursuant to this Grant Agreement shall be considered compensation for purposes
of any pension or retirement plan, insurance plan or any other employee benefit plan of the Company or its subsidiaries, unless otherwise
expressly provided in such plan.

 

11.   No
Guarantee of Continued Service. The Optionee acknowledges and agrees that the right to exercise the Option pursuant to the exercise
schedule hereof is earned only through Continuous Service and such other requirements, if any, as are set forth in Exhibit A (and not
through the act of being hired, being granted an option or purchasing shares hereunder). The Optionee further acknowledges and agrees
that (i) this Grant Agreement, the transactions contemplated hereunder and the exercise schedule set forth herein do not constitute an
express or implied promise of continued employment or service for the exercise period or for any other period, and shall not interfere
with the Optionee’s right or the right of the Company or its Subsidiaries to terminate the employment or service relationship at
any time, with or without cause, subject to the terms of any written employment agreement that the Optionee may have entered into with
the Company or any of its Subsidiaries; and (ii) the Company would not have granted this Option to the Optionee but for these acknowledgements
and agreements.

 

12.   Entire
Agreement; Governing Law. The Plan is incorporated herein by reference. The Plan and this Grant Agreement constitute the entire agreement
of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the
Company and the Optionee with respect to the subject matter hereof, and may not be modified adversely to the Optionee’s interest
except by means of a writing signed by the Company and the Optionee. In the event of any conflict between this Grant Agreement and the
Plan, the Plan shall be controlling, except as otherwise specifically provided in the Plan. This Grant Agreement shall be construed under
the laws of the State of Delaware, without regard to conflict of laws principles.

 

    -3-

     

    

 

13.   Opportunity
for Review. Optionee and the Company agree that this Option is granted under and governed by the terms and conditions of the Plan
and this Grant Agreement. The Optionee has reviewed the Plan and this Grant Agreement in their entirety, has had an opportunity to obtain
the advice of counsel prior to executing this Grant Agreement and fully understands all provisions of the Plan and this Grant Agreement.
The Optionee hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions
relating to the Plan and this Grant Agreement. The Optionee further agrees to notify the Company upon any change in the residence address
indicated herein.

 

14. Section 409A. This
Option is intended to be excepted from coverage under Section 409A and shall be administered, interpreted and construed accordingly. The
Company may, in its sole discretion and without the Optionee’s consent, modify or amend the terms of this Grant Agreement, impose
conditions on the timing and effectiveness of the exercise of the Option by Optionee, or take any other action it deems necessary or advisable,
to cause the Option to be excepted from Section 409A (or to comply therewith to the extent the Company determines it is not excepted).

 

15.   Recoupment.
In the event the Company restates its financial statements due to material noncompliance with any financial reporting requirements under
applicable securities laws, any shares issued pursuant to this Agreement for or in respect of the year that is restated, or the prior
three years, may be recovered to the extent the shares issued exceed the number that would have been issued based on the restatement.
In addition and without limitation of the foregoing, any amounts paid hereunder shall be subject to recoupment in accordance with The
Dodd–Frank Wall Street Reform and Consumer Protection Act and any implementing regulations thereunder, any clawback policy adopted
by the Company or as is otherwise required by applicable law or stock exchange listing conditions.

 

[Signature Page Follows]

 

    -4-

     

    

 

IN WITNESS WHEREOF, the parties hereto have executed
this Grant Agreement as of the date set forth in Exhibit A.

 

	 	ZYVERSA THERAPEUTICS, INC.
	 	 
	 	By:	 
	 	 	Name:
	 	 	Title:
	 	 
	 	OPTIONEE
	 	 
	 	Name:

 

    -5-

     

    

 

EXHIBIT
A

 

NONQUALIFIED STOCK OPTION GRANT AGREEMENT

 

ZYVERSA THERAPEUTICS, INC.

 

(a). Optionee’s
Name: _____________________________________ 

 

(b). Date of Grant: __________________________

 

 (c). Number of Shares Subject to the
Option: __________________________ 

 

(d).   Exercise
Price: $______ per Share

 

 (e). Expiration Date: _____________________ 

 

 (f). Vesting
Schedule: The Option shall vest as to [twenty-five percent (25%)] of the Shares subject thereto on the one-year anniversary of the
Date of Grant (the “First Vesting Date”) and as to the remaining [seventy-five percent (75%)] of the Shares subject thereto
ratably over the next [thirty-six (36)] months thereafter beginning on the first monthly anniversary of the First Vesting Date and continuing
on each monthly anniversary of the First Vesting Date thereafter; provided that Optionee is in Continuous Service on each such respective
vesting date.

 

_______ (Initials)

 Optionee

 

_______ (Initials)

Company Signatory

 

    -6-

     

    

 

EXHIBIT
b

 

ZYVERSA THERAPEUTICS, INC.

2022 OMNIBUS EQUITY INCENTIVE PLAN

 

STOCK OPTION EXERCISE NOTICE

 

Zyversa Therapeutics, Inc.

2200 N Commerce Pkwy STE 208

Weston, FL 33326

Attention: Chief Financial Officer

 

1. Exercise of Option. Effective as of
today, ________________, 202__ (the “Exercise Date”), the undersigned (“Purchaser”) hereby elects to purchase ________
shares (the “Shares”) of the Common Stock of Zyversa Therapeutics, Inc. (the “Company”) under and pursuant to
the Stock Option Grant Agreement dated _____________, 202_ (the “Option Agreement”). Pursuant to the Option Agreement, the
aggregate purchase price for the Shares is $_____________ (the “Purchase Price”). Capitalized terms used herein and not otherwise
defined shall have the meaning assigned thereto under the Zyversa Therapeutics, Inc. 2022 Omnibus Equity Incentive Plan (the “Plan”).

 

2. With respect to payment of the Purchase Price,
select A or B as follows:

 

A. [   ] Full Payment. Purchaser herewith
makes payment of a check the full Purchase Price to the Company, either:

 

[   ] by enclosing a check payable
to Zyversa Therapeutics, Inc., or

 

[   ] by transfer of funds by
wire transfer to the Company.

 

B. [   ] Cashless Exercise. Purchaser elects
to exercise via “cashless exercise” through a broker approved by the Company, and agrees to execute and deliver all appropriate
forms as may be required by such broker and/or the Company. I hereby authorize the broker will pay to the Company the Purchase Price plus
an amount sufficient to cover all applicable taxes, as determined by the Company.

 

3. Rights as Shareholder. Until the issuance
(as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company) of the Shares,
no right to vote or receive dividends or any other rights as a shareholder shall exist with respect to the Shares covered by the Option,
notwithstanding the exercise of the Option. The Shares so acquired shall be issued to the Optionee as soon as practicable after exercise
of the Option. No adjustment will be made for a dividend or other right for which the record date is prior to the date of issuance.

 

    -7-

     

    

 

4. Tax Consultation. Purchaser understands
that Purchaser may suffer adverse tax consequences as a result of Purchaser’s purchase or disposition of the Shares. Purchaser represents
that Purchaser has consulted with any tax consultants Purchaser deems advisable in connection with the purchase or disposition of the
Shares and that Purchaser is not relying on the Company for any tax advice.

 

5. Entire Agreement; Governing Law. The
Option Agreement is incorporated herein by reference. This Agreement and the Option Agreement constitute the entire agreement of the parties
with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and the
Purchaser with respect to the subject matter hereof, and may not be modified adversely to the Purchaser’s interest except by means of
a writing signed by the Company and Purchaser. This agreement is governed by the internal substantive laws, but not the choice of law
rules, of the State of Delaware.

 

	Submitted by:	 	Accepted by:
	 	 	 
	PURCHASER 	 	ZYVERSA THERAPEUTICS, INC.
	 	 	 
	 	 	By:	                     
	 	 	 
	 	 	 
	Print Name 	 	Print Name/Title
	 	 	
	Date:	                              	 	Date:	                                        

 

    -8-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00348-of-00352.parquet"}]]